-The Telegraph Calcutta: Mamata Banerjee's zeal for a new anti-fraud bill could delay action against Saradha for months but has only a few differences with the old Left-sponsored bill her government has withdrawn, officials said today. "Except for three provisions and a few other minor changes, the language of the two bills is identical," a law department official said. A senior Writers' bureaucrat said the legislative steps that the new bill must...
More »SEARCH RESULT
Total Matching Records found : 1137
The Larger Implications of the Novartis Glivec Judgment-Sudip Chaudhuri
-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...
More »Parliamentary panel opposes automatic promotion under RTE-Aarti Dhar
-The Hindu Opposing the provision of automatic promotions till Class VIII under the Right of Children to Free and Compulsory Act, 2009, a Parliamentary committee has asked the Ministry of Human Resource Development to "rethink" the policy as a student may not be motivated to work hard if promotion was guaranteed. Expressing concern over the quality of education under the RTE regime and the learning outcome, the panel has asked the Ministry...
More »Proactive for Ambani, but UPA sleeping over CAG recommendations-Sujay Mehdudia
-The Hindu The UPA government has been proactive in responding to demands by Reliance Industries Limited (RIL) for a raise in natural gas prices, but has shown little urgency in implementing the Comptroller and Auditor General's (CAGs) recommendations made in 2009 on the audit of oil and gas contractors such as RIL. The CAG recommendation would have facilitated the intense scrutiny of the prices and profits made by the contractors. The Petroleum Ministry's...
More »Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »
